Company Overview

Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis, and monitoring solutions serving the nuclear energy, medical, defense, and research industries. The company designs and manufactures hardware, software, and integrated systems used to ensure safety, compliance, and performance in environments involving ionizing radiation. Its offerings support mission‑critical applications such as nuclear power plant operations, cancer treatment quality assurance, national security, and scientific research.

The company operates through two primary business lines—Nuclear & Safety and Medical—which together represent its core revenue drivers. Mirion’s strategic positioning is built on long product lifecycles, high regulatory barriers to entry, and deep customer integration, particularly in nuclear facilities and hospitals. Mirion traces its roots to several legacy radiation‑measurement businesses, including Canberra Industries, and was formed in its current structure through private equity ownership before becoming a publicly traded company in 2021 following a merger with a special purpose acquisition company.

Business Operations

Mirion generates revenue through the sale of radiation detection instruments, dosimetry devices, imaging and monitoring systems, software platforms, and recurring services such as calibration, maintenance, and regulatory compliance support. The Nuclear & Safety segment serves nuclear power plants, fuel cycle facilities, government laboratories, and defense customers with radiation monitoring systems, detectors, and analytical software. The Medical segment focuses on quality assurance, imaging, and radiation therapy safety solutions for hospitals, cancer centers, and clinical research institutions.

Operations span both domestic and international markets, with manufacturing, engineering, and service capabilities distributed across North America, Europe, and Asia. Mirion controls proprietary detector technologies, dosimetry systems, and software platforms that are embedded in customer workflows. Notable subsidiaries include Mirion Technologies (Canberra) and Sun Nuclear, both of which operate as branded business units within the broader corporate structure.

Strategic Position & Investments

Mirion’s strategy emphasizes growth in markets supported by long‑term secular trends, including nuclear power life‑extension, new reactor development, medical radiation therapy expansion, and increased regulatory focus on radiation safety. The company continues to invest in digitalization, software‑enabled services, and integrated solutions that increase recurring revenue and customer retention. Emerging areas of involvement include support for advanced nuclear technologies and fusion research, where precise radiation measurement is critical.

Key investments and acquisitions have reinforced Mirion’s portfolio and market reach. The acquisition of Sun Nuclear significantly expanded its medical segment, particularly in radiation therapy quality assurance. Mirion has also invested in service‑based dosimetry and monitoring capabilities to strengthen its recurring revenue model. Data on additional recent acquisitions beyond publicly disclosed transactions is inconclusive based on available public sources.

Geographic Footprint

Mirion Technologies is headquartered in North America, with its corporate headquarters in Atlanta, Georgia. The company maintains a substantial operational presence across Europe and Asia, supporting customers in more than 60 countries. Its geographic diversification aligns with the global distribution of nuclear power facilities, medical institutions, and government research organizations.

Manufacturing, research and development, sales, and service operations are strategically located near major customer markets, enabling compliance with local regulations and rapid technical support. International operations contribute a significant portion of revenue, reflecting Mirion’s role as a global supplier in highly specialized and regulated industries.

Leadership & Governance

Mirion is led by an executive team with experience across nuclear technology, industrial manufacturing, and regulated markets. Leadership emphasizes safety culture, regulatory compliance, and long‑term customer partnerships as central elements of the company’s strategic vision.

Key executives include:

• Thomas D. Logan – Chief Executive Officer
• Bryan Hanson – Chief Financial Officer
• Loïc Eloy – President, Nuclear & Safety Segment

Information on additional executive roles and board committee structures is limited in publicly available summaries; data inconclusive based on available public sources.